Background:Acute exacerbation of chronic obstructive pulmonary disease (AECOPD) is considered to be an important cause of morbidity, intensive care unit (ICU) admissionand mortality in COPD patients. Objectives:to identify the factors which could predict the outcome ofCOPDpatients. Patients and methods: A prospective study was conducted at Chest Department of Sohag University Hospital during the period from May 2016 to August 2017 and included 101 COPD patients with AECOPD. Patients were deemed to have AECOPD if this diagnosis appeared on their clinical histories. The studied variables included clinical parameters (symptoms & signs), spirometry and laboratory tests (complete blood count, serum creatinine, liver function tests -ALT, AST and serum albuminserum electrolytes, arterial blood gas test and sputum cultures), radiological data(plain chest x-ray, CT chest (if indicated) and echocardiographic data for every patient. The outcome in the studyincluded improvement or non-improvement (referral to ICU or death). Results:The study included 101 patients with AECOPD, the mean age of the patients was 60years, 66.34% of them were males and 33.66% females, according tothe outcome; 83 cases improved, 18 cases had poor outcome (i.e. need ICU admissionordied). Bacterial growth, in the sputum culture, was recorded in 65.35% of the cases. The most frequently recorded bacterial organism were: Streptococcus pneumonia, Haemophilus influenza and Pseudomonas aeruginosa (14.85%, 13.87% and 10.89% respectively). The factors, which had significant relation to poor outcome, were: male gender (P=0.04), frequent exacerbation (P=0.003), history of ≥2 hospital admission and previous ICU admission in the last year(P= 0.004 and 0.003 in order), history of prior LTOT(P=0.006),altered consciousness, tachycardia, tachypnea, fever, flapping tremor, pedal edema (P=0.009, 0.02, ˂0.0001, 0.03,˂0.0001and0.008 in order), associated comorbidities (bronchiectasis, corpulmonale and DM; P=0.047, 0.005 and 0.008respectively), lower mean values of pH, PaO 2 , SaO 2 and higher mean values of PaCO 2 on admission (P=0.007, 0.003, 0.001 and 0.01in order), leukocytosis, thrombocytopenia, elevated serum creatinine, elevated liver enzymes and hypoalbuminemia (P= 0.008, 0.001, 0.02, 0.001and0.007 in order), presence of cardiomegaly or bronchiectaic changes as radiological findings (P= 0.001 and 0.047 in order), severe pulmonary artery hypertension as an echocardiographic finding (P=0.03), lower mean values of FEV1and FVC(P=0.01 and 0.02 in order), Staph. aureusand P. aeruginosa isolation in sputum cultures (P˂0.0001 and 0.002 in order). Conclusion:The significant factors in predicting poor outcome of AECOPD were: male gender, frequent exacerbations, prior hospital (≥2 hospital admission/year) and ICU admission in the last year, history of prior LTOT, associated comorbidities (bronchiectasis,corpulmonale and DM), consciousness alteration, tachycardia, tachypnea, fever, flapping tremor, lower limb edema, arterial blood gas parameters on SOHAG MEDICAL JOURNAL Acute Exacerbation of Chronic Obstructive Vol. 23 No.1 Jan 2019 Esraa A. Saad.et al 16 admission (higher mean values of PaCO 2 and lower mean values of pH, PaO 2 and SaO 2 ), leukocytosis, thrombocytopenia, elevated serum creatinine, higher mean levels of ALT and AST, hypoalbuminemia, presence of cardiomegaly or bronchiectatic changes as radiological findings, severe pulmonary artery hypertension as an echocardiographic finding, lower mean values of FEV 1 and FVC, P.aeruginosa and Staph.aureus isolation in sputum cultures.
Introduction
The Global Initiative for Obstructive Lung Disease (GOLD) defined an AECOPD as an acute worsening of respiratory symptoms that result in additional therapy (GOLD, 2018) . It is important to identify the prognostic factors of it as a respect to the fact that AECOPD is an important and common cause of emergency room visits and is a major cause of morbidity and death and the fact that following an acute exacerbation, many patients experience a transient or permanent decrease in the quality of life (Connor et al., 1996 &Seemungal et al., 2000 , thus the economic and social burden of COPD exacerbation are extremely high (Lopez et al. 2006) . The aim of the study: We aimedto identify thefactors which could predict the outcome of acute exacerbation in COPD patients. Patients and methods:This prospective study was conducted in the Chest Department of Sohag University Hospital. The study included 101 patients with AECOPD who were admitted to the department from outpatient chest clinic and emergency department during the period from May 2016 to August 2017. The study was approved by the medical ethics committee of Sohag Faculty of Medicine. Consent was taken from every patient to participate in the study.Patients who were <40 years old, critical patients who needed ICU admission at the time of first evaluation in emergency room, and the patients who had pulmonary tuberculosis or acute coronary syndrome were excluded from the study. Acute exacerbation of COPD was diagnosed using the following symptoms (Anthonisen et al., 1987):recent rapid worsening of dyspnea, presence of sputum purulence and increase in sputum volume.According to these symptoms, exacerbations were classified into (Anthonisen et al., 1987):  Type 1 (severe AECOPD): exacerbations include increased dyspnea, sputum volume and sputum purulence.  Type 2 (moderate AECOPD):
exacerbations involve any two of those symptoms.  Type 3 (mild AECOPD): exacerbations includeonly one of those symptoms plus one of the following (an upper respiratory tract infection in the past 5 days, fever without other causes, increased wheezing or cough, or an increase in heart rate or respiratory rate by 20% compared with the baseline readings). Patients who had positive sputum culture, fever or purulent sputum, were considered to have infectious AECOPD, while the others who had none of them were considered to have non-infectious AECOPD (Elkorashy et al., 2014). All patients were subjected to full clinical evaluation (history and examination), plain chest xray,electrocardiogram, computed tomography (if indicated), abdominal ultrasonography, echocardiography, complete blood count and arterial blood gases analysis on admission (pH, PaCO 2 , PaO 2 , SaO 2 % &HCO 3 )the samples were analyzed using automated blood gases analyzer (ABL800 FLEX blood gas analyzer, radiometer, USA), blood chemistrywas done, including serum creatinine, liver enzymes (ALT&AST), serum albumin and serum electrolytes (Na + , K + , C a ++ ) (Roche/Hitachi cobas c 311systen, Germany).
Sputum examination:
Bacterial sputum cultures was done for every patient. At hospital admission, the sputum was collected by spontaneous or induced expectoration (using nebulized hypertonic saline). Early morning sputum samples were collected in sterile containers before starting antibiotic treatment at the hospital. The samples were transferred to the bacteriology laboratory of Sohag University Hospital where they were examined and the results were reported by specialists.The sputa were cultured only if the quality criteria were met in a sputum Gram stain (<10 epithelial cells and >25polymorphonuclear leukocytes per low magnification field x100). Samples were cultured on sheep blood agar plates and mcConkey agar (Dylan Inc., Edomonton, Alberta), then incubated at 37 • C in a moist atmosphere containing 5% CO 2 (CO 2 incubator, Grant Instruments Ltd) for 24hours (if no results further incubation until 48hr was done). Only isolates with higher than 105 colony forming units were reported as a positive growth (Murray et al., 2003) .VITEK 2 compact automated microbial system (bioMérieux, Inc. Hazelwood, USA) was used for identification of the bacterial microorganisms using colorimetric reagent cards that are incubated and interpreted automatically.
Pulmonary function tests (PFT(:
Pulmonary function tests data were obtained from the previous records of the patients and when these were not available, PFTs were done while the patients were stable and free from all the symptoms and the signs of acute exacerbation (at least after two weeks). The data were obtained for 91 patients, as previous records and follow up data for the others were not available. PFTs were performed with a spirometer of computer processing (Jaeger Master Screen Diffusion, Viasys Healthcare, Gmbh, Hoechberg, Germany). Postbronchodilator spirometry measurements were recorded for the studied population to measure the values of forced expiratory volume in 1 st second (FEV 1 ), forced vital capacity (FVC) and FEV 1 /FVC ratio. Postbronchodilator values were used for the evaluation of COPD severity, according to GOLD guidelines (Stage I: mild COPD, FEV 1 > 80% of predicted FEV 1 -Stage II: moderate COPD, 50%≤ FEV 1 <80%-Stage III: severe COPD, 30%≤ FEV 1 <50%-Stage IV: very severe COPD, FEV 1 <30%) (GOLD, 2018). Outcome in the studied population was assessed as the following (Chow et al., 1992 &Mantero et al., 2017 :  Improvement was considered if patients continued their treatment in the ward until resolution or reduction in the symptoms and signs occurred without appearance of new symptoms or signs associated with the exacerbation.  Non improvement was considered when worsening of symptoms or signs occurred and led toreferral to intensive care unit (ICU) or death. Statistical analysis: Data was analyzed using STATA intercooled version 14.2. Quantitative data was represented as mean, standard deviation. Data was analyzed using student t-test to compare means of two groups. When the data was not normally distributed Mann-Whitney test was used. Qualitative data was presented as number and percentage and compared using either Chi square test or fisher exact test. Odds ratios were obtained from logistic regression analysis. P value was considered significant if it was less than 0.05 .
Results
The study included 101 patient with AECOPD with mean age of 60 years, 66.34% of the cases were males and 33.66% of the cases were females. 47.52% of the cases were ex-smokers, 31.68% of the cases were current smokers and 20.79% of the cases were non-smokers( 
Table(5): Relation between patient ' s outcome and demographic characteristics

Table (6): Relation between the patient ' s outcome and the characteristics of the disease and current exacerbation
Table (14): Relation between the etiology of AECOPD and patient's outcome
As regard the etiology of AECOPD, table (14) shows that bacterial infection was more frequent among the patients who had poor prognosis but statistically insignificant(P=0.09). , 1987&Groenewegen et al., 2003 . However, our study shows that there were no statistically significant relation between the outcome and the age (P=0.2), this result supports the findings of Gunen et al. that showed no significant relation between the age and outcome in patients with AECOPD (Gunen et al., 2005) . As regard the gender, our study found that male gender is a significant predictor of poor outcome ofAECOPD (P=0.04) in agreement with Singanayagam et al. (Singanayagam et al., 2013) . In our community, female smoking is of less common than that of male gender, so most COPD in females is due to causes other than smoking. This may explain the milder form of the disease in females, as it was found that cigarette smokers have a higher prevalence of respiratory symptoms and lung function abnormalities, a greater annual rate of decline in FEV 1 and a greater COPD mortality rate than nonsmokers (Rabe et al., 2007) . Moreover, morbidity due to COPD was thought to be greater in men than women (Chapman, 2004) . In contrast, other studies found no relation between the gender and clinical outcome in patients with AECOPD (Yousif et al., 2016 &Elgazzar, 2018). In our study, it was shown that poor outcome is significantly influenced by the higher frequencies of COPD exacerbation in the previous 12 months (≥2 exacerbation /year) (P=0.003). Gaude et al. found that frequent exacerbation was a predictor of poor outcome (death or treatment failure of AECOPD) (P=0.001) in their univariate logistic regression analysis (Gaude et al., 2015) . Risk factors associated with this type of patient could be due to the rapid decline in lung function and respiratory bacterial or viral colonization. (Donaldson et al., 2002) . According to the present study, prior hospital admissions (≥2 admission/year) and prior ICU admission, in the last year, also could predict poor outcome (P=0.004 and 0.003 respectively). As regard prior hospitalization, we are in line with Gaude et al. who reported the prior hospitalization as a predictor of poor outcome, i.e. death or readmission, (P= 0.04) (Gaude et al., 2015) . Elgazzar study also mentioned that the prior ICU admission was a predictor of poor outcome (P=0.042). These results could be explained as both history of previous hospitalization or previous ICU admission due to AECOPD reflect the severity of the underlying disease, poor pulmonary reserve, poor compliance to treatment and may be the resistance of infection (Elgazzar, 2018) . In our study, we also found that there was a significant relation between priorLTOT and poor outcome (P= 0.006). These results coincided with the previous studies that showed a significant relation between the LTOT and outcome in patients with AECOPD LTOT reflects more severe stages of the disease that could be associated with corpulmonale, (which is a wellknown adverse prognostic factor) thus the relation between LTOT and poor outcome could be explained (Connors et al., 1996 &Yohannes et al., 2005 . As regard the clinical parameters: altered consciousness and flapping tremor were predictors of outcome in our study (P=0.009 & ˂0.0001 respectively).Theyare considered as neurological manifestation of the hypercapnic encephalopathy which is caused by higher values of PaCO 2 and respiratory acidosis. Roche et al also found that these factors were predictors of ICU admission or mortality (Roche et al., 2008) . With regard to vital signs, the present study also showed that the patients with poor outcome had higher mean rates of pulse and respiration, on admission, in comparison with patients with good outcome (P= 0.02 and ˂0.0001 in order). Tabak and collaegues considered tachycardia as a predictor of hospital mortality in patients with AECOPD (Tabak et al., 2009). Tachycardia may capture interactions between volume status, hypoxemia, and general distress.The risk of death or readmissions is increased in patients presenting severe tachypnea already noted across different studies, perhaps because respiratory rate is at an intersection ofmanypathophysiological processes, such as muscle dysfunction,respiratory failure and metabolic acidosis (Cretikos et al., 2008 &Flattet et al., 2017). Our results also demonstrates that fever had as a significant relation with the poor outcome (P= 0.03). In agreement with us,fever was reported as a predictor of poor outcome, in ventilated COPD patients, in Elgazzar study which explained it byacting as a sign of systemic inflammatory response which may reflect the severity of the infection (Elgazzar, 2018) . Our study also demonstrates that pedal edema is a predictor sign for poor outcome (P=0.008), thus coincided withRoche et al. and Singanayagam et al. (Roche et al., 2008 &Singanayagam et al., 2013 . It could be explained as lower limb edema in COPD patient reflects the presence of right sided heart failure and more severe illness. With respect to the pattern of comorbidities, in the present study, bronchiectasis andbronchiectatic changes in radiological assessmentwerefound to be significant predictors for poor outcome in AECOPD (P=0.047). Previous research foundthat the patients with COPD and coexisting bronchiectasis have greater bronchial inflammation and greater chronic colonization of bronchial mucosa by a potentially pathogenic microorganism, this can lead to more frequent exacerbations with longer duration (Sethi and Murphy, 2001 & Patel et al., 2002 . In agreement with us, Du et al. found that comorbid bronchiectasis in COPD patients increased the risk of mortality (Du et al., 2016) . In contrast to our results, Crisafulli et al.found that bronchiectasis had no effects on the clinical impact on hospital admission, the clinical presentation, the rate and the risk of short and long term mortality. Moreover, they found that in the patients with AECOPD, the prevalence of ICU admission in the patients with bronchiectasis was less than the prevalence of ICU admission in the patients without bronchiectasis (Crisafulli et al., 2018(. Corpulmonale and cardiomegaly weresignificant predictors for poor outcome in our results (P=0.005 and 0.001 respectively). Previous studies considered corpulmonale to be a predictor of poor outcome in AECOPD (Connors  et  al.,  1996  and  Singanayagam  et al., 2013).Cardiomegaly could be reflect presence of corpulmonale. It can be explained as they reflect the severity of the disease and could aggravate the acute illness. In our study, diabetes mellitus appeared to be a significant factor in poor outcome prediction (P= 0.008). In Baker et al., the higher blood glucose significantly predicted adverse clinical outcomes (death or prolonged hospital stay) in AECOPD (Baker et al., 2006) . In acute illness, cytokines, hormones and hypoxia up regulate expression and membrane localization of glucose transporters in many cell types. Cellular glucose overload results in increased glucose metabolism, in turn increasing superoxide and peroxynitrite production which may impair mitochondrial activity (Van den Berghe, 2004).Hyperglycaemia could also cause adverse outcomes from AECOPD by predisposing to infection through systemic or local effects on host immunity or bacterial growth (Philips et al., 2003 & Wood et al., 2004 . With respect to the arterial blood gas on admission: lower mean values of arterial blood pHat admission was a significantly associated with the poor outcome, according to our study(P=0.007).In contrast, Tsimogianniet al found that arterial blood pH was not related to mortality, and the author attributed this to the fact that the patients with significant respiratory acidosis were transferred to the intensive care unit and subsequently excluded from their study (Tsimogianni et al., 2009 (. In addition, lower values of PaO 2 and SaO 2 % were found to be poor outcome predictors according to our study(P=0.003&0.001).Gunen et al. also found that lower values of PaO 2 are predictors of poor outcome andthey explained that because low PaO 2 is a direct evidence for limited pulmonary reserve and increased ventilation/perfusion mismatch, thus, could reflects the severity of the underlying disease. These patients became less tolerant to alterations in their clinical condition, thus, showing a poorer prognosis (Gunen et al., 2005) .Higher mean values of PaCO 2 at hospital admission also was significantly associated with the poor outcome(P= 0.01).As regard thesurvival in AECOPD,previous studies prescribed a worse prognosisin the case of high value of PaCO 2 &Flattet et al., 2017 . PaCO 2 is a reflection of alveolar ventilation and is a reflection of the severity of the exacerbation. As shown in the present study, poor outcome is related to leukocytosis(P= 0.008). In agreement with this, leukocytosis was found as a factor with a significant relation to poor outcome in hospitalized patients with AECOPD admitted to ICU, i.e. death(Ashmawi et al., 2017). Leukocytosis is an indicator of inflammation which reflects presence of infection in those patients so its relation with poor outcome in AECOPD could be explained. On the other hand, Elgazzar study foundthat leukocytosis were not related to outcome in AECOPD (Elgazzar et al., 2018) . Also, in the present study poor outcome was related to thrombocytopenia (P=0.001).In agreement with that, thrombocytopenia was found to be a significant predictor of poor outcome (i.e. hospital mortality, need for ICU admission or mechanical ventilation, P=0.001, 0.008 and 0.001 respectively) in patients with AECOPD (Rahimi-Rad et al., 2015). Thrombocytopenia may reflect some pathophysiologic disturbances, including disseminated intravascular coagulation, sepsis, macrophage activation, vitamin deficiencies, druginduced toxicity orother unidentified factors (Moreau et al., 2007) . The present study showed that higher serum level of creatinine were associated with the risk of poor outcome(P=0.02).Fluttet et al., 2017 also found that impaired renal function is associated with poor outcome (i.e. mortality or readmission). A raised creatinine level in any acute medical condition may also represent an underlying poor hydration state prior to admission . As regard elevated liver enzymes, we also observed that AECOPD patients with elevated serum levels of liver enzymes (ALT and AST) had higher risk of poor outcome(P=0.001). It could be explained by hypoxic hepatitis, due to arterial hypoxia and may be due to hepatic venous congestion in patients of severe decompensated corpulmonale (Henrion et al., 1999) . In our study, we also observed that hypoalbuminemiacould predict poor outcome(P=0.007).The importance of hypoalbuminemia as a predictor of poor outcome of AECOPD was consistent with results from other studies of AECOPD ( According to the echocardiography, severe pulmonary hypertension was a significant predictor of poor outcome in our results (P= 0.03) in agreement with Hurdmanet al. (Hurdman et al., 2013) , it could be explained of that they reflect the severity of the disease and could aggravate the acute illness. Concerning lung function, our study showed that lower mean values of FEV 1 and FVC had significant relation to poor outcome (P=0.01 and 0.02 respectively) and the patient with very severe COPD (stage IV according to GOLD,2018) had the worse outcome than the patients with less severity of the COPD (P=0.02). Such results have been reported in similar studies and are probably explained by the degree of ventilatory impairment and the higher risk of colonization by aggressive bacteria causing exacerbation (Miravitlles et , 2007) .This high prevalence of MRSA in these studies should be an alarm for the increasing prevalence of MRSA among hospitalized patients in our locality.Previous studies agreed with the point that P.aeruginosa isolation in patients with AECOPD is a risk for mortality (Renom et al., 2010&Almagro et al., 2012 . This microorganism is more frequent in advanced stages of the disease, and studies performed in outpatients with acute exacerbation showed an inverse relationship between P.aeruginosa and pulmonary function. Thus, P.aeruginosa is a marker of severity in COPD, which explains the poor prognosis associated with it(Garcia-Vidal et al., 2009)However,Groenewegen et al. and Ko et al. reported that the presence of bacterial isolates did not influence the clinical outcomes, including the length of hospitalization and need for intensive care unit admission, and they did not discover the type of bacteria as a prognostic factor &Ko et al. 2005 ).
Conclusions

Bacterial isolation,in the sputum culture, was found in 65.35% of the patient with acute exacerbation of COPD .
The most common bacterial strains, in sputum culture of patients with AECOPD were: Strept.pneumonia, H. influenza, P.aeruginosa, Staph.aureus .
The significant factors in predicting poor outcome (ICU referral or death) in AECOPD were: male gender, prior LTOT, prior hospital admission (≥2 admission/year) or prior ICU admission in the last year, frequent exacerbations,associated comorbidities (bronchiectasis,corpulmonale and DM), consciousness alteration, tachycardia, tachypnea, fever, flapping tremor, pedal edema, arterial blood gas parameters (higher mean values of PaCO 2 and lower mean values of pH, PaO 2 &SaO 2 ), leukocytosis, thrombocytopenia, elevated serum creatinine,elevated liver enzymes(ALT& AST), hypoalbuminemia, presence of cardiomegaly or bronchiectatic changes as radiological findings, severe pulmonary artery hypertension according to echocardiography, lower mean values of FEV 1 and FVC, and
